An error occurred trying to play the stream. Please reload the page and try again. Close
Mei-Ling Chen, Minister without Portfolio, Executive Yuan & Concurrently Minister,
NATIONAL DEVELOPMENT COUNCIL, R.O.C. (TAIWAN)
International private equity is coming back to Taiwan. US/China trade tensions have reset global supply chains and capital flows. Taiwan’s advantages are being reassessed by local and international investors—tech manufacturing leadership, world-class R&D talent, and well-run local businesses at realistic valuations. Our panel of senior dealmakers discuss the investment outlook for Taiwan.
Moderated by: Chien-Fu Lin, Jeff, Chief Economist, CTBC FINANCIAL HOLDING CO.
Edward Huang, Head of Private Equity for Greater China and Korea, BLACKSTONE
Jim Tsao, Chairman and Head of China, PERMIRA ADVISERS CHINA LIMITED
Hamilton Tang, Managing Director, CDIB CAPITAL GROUP
Paul Yang, Member & CEO of Greater China, KKR
Taiwan’s mid-cap companies are at a crossroads. Founders need growth partners to reach the next level in the face of succession issues, organisational transformation, and limited know-how in international expansion. Still, from deal sourcing, to structuring and alignment of interests, execution is never straightforward. Our panel of professionals demonstrate how private equity can succeed in this compelling segment of the Taiwanese market.
Moderated by: Vincent Chang, President, KPMG Deal Advisory /Head of Private Equity, KPMG TAIWAN
Joyce I-Yin Hsu, Partner, CORNELL CAPITAL
Alex Ying, Managing Director and Head of Buyout Group, CDIB CAPITAL GROUP
Vivian Zheng, Partner, ADVANTAGE PARTNERS
Despite overpriced assets, excessive capital, breakneck investment pace, and unrealised exits, the global healthcare sector remains a top focus among investors of all stages and types. The fundamentals supporting growth remain unchanged and technological advancements have created new opportunities. Investors have dug deeper when sourcing targets across sub-segments, creating products/services that better suit different local markets. Our panel of sector specialists discuss:
Moderated by: Jarret Su, Co-Head of Healthcare & Life Science, KPMG TAIWAN
James Cen Bonsor, Director, Investor Relations, CBC GROUP
James Hsu, President of CDIB Capital Healthcare Ventures, CDIB CAPITAL GROUP
James Huang, Founding Managing Partner, PANACEA HEALTHCARE VENTURE; Managing Partner, KPCB CHINA
James Ieong, Chairman and Managing Partner, PAGODA CAPITAL
Lionel de Saint-Exupéry, Director/Co-CEO, CDIB CAPITAL GROUP
Sophia Cheng, Chief Investment Officer, CATHAY FINANCIAL HOLDINGS
Taiwanese venture capital is back in favour. The National Development Council has ramped up initiatives to encourage global investment in home-grown innovations, as well as facilitate exits via local IPOs. Even so, to ensure a sustainable industry, venture investors need to deliver winning strategies, from seed capital to late stage and exit, to capture this momentum and enable start-ups to commercialise worldwide. Our panel of international investors discuss:
Moderated by: Pamela Fung, Executive Director, MORGAN STANLEY ALTERNATIVE INVESTMENT PARTNERS
Jeff Chang, Managing Director, VERTEX GROWTH FUND
Tina Cheng, Managing Partner, CHERUBIC VENTURES
Masahiko Honma, Co-founder and General partner, INCUBATE FUND
Jessica Liu, Partner, APPWORKS
Edith Yeung, Managing Partner, PROOF OF CAPITAL
Taiwan has become a leading destination for renewables investments in Asia, with a favourable location for offshore wind farms and supportive government policies. Yet, controversies over recent subsidy cuts and political changes may increase regulatory risk. Global experts debate the issues facing the energy market, the deal horizon for renewables, and how to cut through the hype.
Moderated by: Steven Chen, Deputy Head of Markets and Partner, Head of Renewable, Infrastructure, Government and Healthcare, KPMG TAIWAN
Richard Chang, Deputy Country Head – Taiwan, VENA ENERGY
Anthony Lamb, Head of Taiwan, Green Investment Group, MACQUARIE
Kok Leong Toh, Vice President, Private Infrastructure Asia, PARTNERS GROUP (SINGAPORE) PTE. LTD
With an appetite for new strategies and products in the search for yield, Taiwanese LPs and their regional peers continue to increase their exposure to alternatives. However, keeping in mind the risk of macro uncertainties and a potential downturn, they still need to decide where and to whom to allocate capital. Our panellists explain how their approaches are evolving and what managers must do to win commitments.
Moderated by: Andy Tsai, Partner, STEPSTONE GROUP
Saifulbahri Hassan, Senior Vice President, KUMPULAN WANG PERSARAAN (DIPERBADANKAN) [“KWAP”]
Edmond Ng, Founder and Managing Partner, AXIOM ASIA
Sam Robinson, Managing Partner, NORTH-EAST PRIVATE EQUITY ASIA
Rebecca Yang, Head of Alternative Investment, TAIWAN LIFE INSURANCE CO., LTD; Head of Fintech Investment, CTBC FINANCIAL HOLDINGS CO., LTD